Introduced
S. 526
Introduced in Senate · March 11, 2025February 11, 2025
Mr. Grassley (for himself, Ms. Cantwell, Ms. Ernst, Mr. Welch, Mrs. Capito, Mrs. Shaheen, Mr. Marshall, Mr. Heinrich, Mr. Moran, Mrs. Hyde-Smith, Mr. Tillis, and Mr. Rounds) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation
A BILL
To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Pharmacy Benefit Manager Transparency Act of 2025”.